Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Drug Monitoring of New Generation Antiepileptic Drugs: Concrete Benefit, Correlation With Clinical Effects and Usefulness of Saliva Samples

NCT02739282 is registered in ClinicalTrials.gov with Dr Jan Novy as lead sponsor.

NCT NCT02739282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02739282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Drug Monitoring of New Generation Antiepileptic Drugs: Concrete Benefit, Correlation With Clinical Effects and Usefulness of Saliva Samples
Lead sponsor
Dr Jan Novy
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2016
Completion date
January 8, 2019
Enrollment
151 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy